JG
OCUL icon

Jain Global’s Ocular Therapeutix OCUL Stock Holding History

Jain Global’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
+22,942
New +$208K ﹤0.01% 1501
2026
Q1 		– Sell
-25,116
Closed -$305K – 1523
2025
Q4 		$305K Buy
25,116
+9,191
+58% +$112K ﹤0.01% 950
2025
Q3 		$186K Sell
15,925
-3,721
-19% -$44.5K ﹤0.01% 905
2025
Q2 		$182K Buy
+19,646
New +$154K ﹤0.01% 986

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jain Global's OCUL Position: Q2 2026 in Review

Jain Global opened a new position in Ocular Therapeutix (OCUL) in Q2 2026: 22,942 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #1501 among its holdings. This is a return to the name: Jain Global previously reported a position in OCUL as recently as Q4 2025.

Jain Global first reported a position in OCUL in Q2 2025 and has held it in 4 quarters since. The position peaked at $305K in Q4 2025. 263 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Jain Global held 22,942 shares of Ocular Therapeutix worth $225K as of Q2 2026.
  • Ocular Therapeutix was a new Jain Global position in Q2 2026.
  • Ocular Therapeutix made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1501 holding.
  • Jain Global first reported a position in Ocular Therapeutix in Q2 2025 and has held it in 4 quarters since.
  • Jain Global's Ocular Therapeutix position peaked at $305K in Q4 2025.
  • 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.